MAP2 and central nervous system cancer: Western blotting and immunostaining showed increase in molecular markers (GFAP, NeuF-H, β-tubulin-III, MAP2, Nestin, and GAP43) that confirmed the differentiation of glioma to astrocytes (Figure 5B,C).